A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and ...
A proof-of-concept study has created a blueprint for producing prostate cancer treatment more efficiently. Researchers at the ...
For manufacturers, medical device companies, and laboratories that use the commercial diagnostic tests they produce, ...
U.S. President Donald Trump's executive order to accelerate psychedelic drug development has raised hopes among companies ...
SAN DIEGO, CA, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- Which CRO Is Good at Protein Degradation? Key ...
Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.
The FDA has introduced models intended to accelerate rare disease drug development, but recent reversals of guidance from the ...
Access to mifepristone, approved by FDA in 2000, is regulated by a "Risk Evaluation and Management Strategy" (REMS). Under ...
Researchers at The University of Texas Medical Branch (UTMB) have identified how a key enzyme called ATR protects DNA from ...
NASA has enabled scientists to study the impact of microgravity on drug development for decades, beginning with the Space ...
More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.
Industry representatives, patients, and regulators shared their perspectives on the reforms to the EU pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results